Casa
nmmm

ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.

Por um escritor misterioso

Descrição
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Ben Yeomans – Data Scientist
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
ROC curves for predicting the 1‐, 3‐, and 5‐year OS in the
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Serum interleukin‐33 as a novel marker for long‐term prognosis and
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Utility of the Signal-to-Cutoff Ratio and Antigen Index from
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Development and validation of a multimodal neuroimaging biomarker
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Association of Glasgow coma scale and endotracheal intubation in
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Nomogram for predicting 3‐ and 5‐year overall survival rates of
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Lipoprotein(a) Serum Concentration and Apolipoprotein(a) Phenotype
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
The binormal model for ROC curves - The DO Loop
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
ROC Curves and Precision-Recall Curves for Imbalanced
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
ERα determines the chemo-resistant function of mutant p53
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Utility of the Signal-to-Cutoff Ratio and Antigen Index from
ROC curve analysis to predict 3‐ and 5‐year OS rates in NMMM Patients.
Development and validation of a clinical and genetic model for
de por adulto (o preço varia de acordo com o tamanho do grupo)